Paion's Remimazolam superior to midazolam in study

Paion AG (Xetra:PA8) said Remimazolam ( CNS 7056) was superior to midazolam in the Phase IIb Study CNS7056-004 trial to provide sedation in 160 patients undergoing a colonoscopy. The GABA A receptor m...